193 related articles for article (PubMed ID: 8675223)
1. Agalactosyl IgG and beta-1,4-galactosyltransferase gene expression in rheumatoid arthritis patients and in the arthritis-prone MRL lpr/lpr mouse.
Jeddi PA; Bodman-Smith KB; Lund T; Lydyard PM; Mengle-Gaw L; Isenberg DA; Youinou P; Delves PJ
Immunology; 1996 Apr; 87(4):654-9. PubMed ID: 8675223
[TBL] [Abstract][Full Text] [Related]
2. Reduced galactosyltransferase mRNA levels are associated with the agalactosyl IgG found in arthritis-prone MRL-lpr/lpr strain mice.
Jeddi PA; Lund T; Bodman KB; Sumar N; Lydyard PM; Pouncey L; Heath LS; Kidd VJ; Delves PJ
Immunology; 1994 Nov; 83(3):484-8. PubMed ID: 7835974
[TBL] [Abstract][Full Text] [Related]
3. Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice.
Mizuochi T; Hamako J; Nose M; Titani K
J Immunol; 1990 Sep; 145(6):1794-8. PubMed ID: 2391420
[TBL] [Abstract][Full Text] [Related]
4. Suppressor T-cell activity in MRL/Mp-lpr/lpr mice: differential effects on primary and memory antibody responses of MRL/Mp-lpr/lpr and MRL/Mp-+/+ spleen cells to thymus dependent and thymus independent antigens in vitro.
Wilson DA
Cell Immunol; 1985 Dec; 96(2):312-26. PubMed ID: 2943418
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 contributes to high level IgG production in the murine MRL/lpr lupus model.
Singh AK; Lebedeva TV
Immunol Invest; 1994 Aug; 23(4-5):281-92. PubMed ID: 7959962
[TBL] [Abstract][Full Text] [Related]
6. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis.
Bond A; Cooke A; Hay FC
Eur J Immunol; 1990 Oct; 20(10):2229-33. PubMed ID: 2242757
[TBL] [Abstract][Full Text] [Related]
7. Novel recombinant congenic mouse strain developing arthritis with enthesopathy.
Mori S; Tanda N; Ito MR; Oishi H; Tsubaki T; Komori H; Zhang MC; Ono M; Nishimura M; Nose M
Pathol Int; 2008 Jul; 58(7):407-14. PubMed ID: 18577108
[TBL] [Abstract][Full Text] [Related]
8. [Studies on abnormal immune responses to thymus-dependent antigens in autoimmune MRL/MpJ-lpr/lpr mice].
Kobayashi S
Hokkaido Igaku Zasshi; 1987 May; 62(3):451-60. PubMed ID: 2956175
[TBL] [Abstract][Full Text] [Related]
9. Abnormal IgG galactosylation in MRL-lpr/lpr mice: pathogenic role in the development of arthritis.
Kuroda Y; Nakata M; Hirose S; Shirai T; Iwamoto M; Izui S; Kojima N; Mizuochi T
Pathol Int; 2001 Dec; 51(12):909-15. PubMed ID: 11844062
[TBL] [Abstract][Full Text] [Related]
10. IgG3 production in MRL/lpr mice is responsible for development of lupus nephritis.
Takahashi S; Nose M; Sasaki J; Yamamoto T; Kyogoku M
J Immunol; 1991 Jul; 147(2):515-9. PubMed ID: 2071894
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal IgM rheumatoid factors derived from arthritic MRL/Mp-lpr/lpr mice.
Theofilopoulos AN; Balderas RS; Hang L; Dixon FJ
J Exp Med; 1983 Sep; 158(3):901-19. PubMed ID: 6224885
[TBL] [Abstract][Full Text] [Related]
12. T cell influence on superantigen-induced arthritis in MRL-lpr/lpr mice.
Mountz JD; Zhou T; Long RE; Bluethmann H; Koopman WJ; Edwards CK
Arthritis Rheum; 1994 Jan; 37(1):113-24. PubMed ID: 7907476
[TBL] [Abstract][Full Text] [Related]
13. Abnormal IgG galactosylation and arthritis in MRL-Fas(lpr) or MRL-FasL(gld) mice are under the control of the MRL genetic background.
Kuroda Y; Nakata M; Nose M; Kojima N; Mizuochi T
FEBS Lett; 2001 Oct; 507(2):210-4. PubMed ID: 11684100
[TBL] [Abstract][Full Text] [Related]
14. Expression of heterozygous lpr gene in MRL mice. I. Defective T-cell reactivity and polyclonal B-cell activation.
Carlsten H; Tarkowski A
Scand J Immunol; 1989 Oct; 30(4):457-62. PubMed ID: 2814366
[TBL] [Abstract][Full Text] [Related]
15. High expression of interleukin-1beta in the corneal epithelium of MRL/lpr mice is under the control of their genetic background.
Okamoto M; Takagi M; Kutsuna M; Hara Y; Nishihara M; Zhang MC; Matsuda T; Sakanaka M; Okamoto S; Nose M; Ohashi Y
Clin Exp Immunol; 2004 May; 136(2):239-44. PubMed ID: 15086386
[TBL] [Abstract][Full Text] [Related]
16. Identification of a B cell differentiation factor(s) spontaneously produced by proliferating T cells in murine lupus strains of the lpr/lpr genotype.
Prud'Homme GJ; Park CL; Fieser TM; Kofler R; Dixon FJ; Theofilopoulos AN
J Exp Med; 1983 Feb; 157(2):730-42. PubMed ID: 6600490
[TBL] [Abstract][Full Text] [Related]
17. B lymphocytes from the autoimmune-prone mouse strain MLR/lpr manifest an intrinsic defect in tetraparental MRL/lpr in equilibrium DBA/2 chimeras.
Nemazee D; Guiet C; Buerki K; Marshak-Rothstein A
J Immunol; 1991 Oct; 147(8):2536-9. PubMed ID: 1918976
[TBL] [Abstract][Full Text] [Related]
18. IL-1 beta gene expression in B cells derived from the murine MRL/lpr model of lupus.
Mao C; Singh AK
Autoimmunity; 1996; 24(2):71-9. PubMed ID: 8986320
[TBL] [Abstract][Full Text] [Related]
19. CS-A therapy in MRL-lpr/lpr mice: amelioration of immunopathology despite autoantibody production.
Mountz JD; Smith HR; Wilder RL; Reeves JP; Steinberg AD
J Immunol; 1987 Jan; 138(1):157-63. PubMed ID: 3537128
[TBL] [Abstract][Full Text] [Related]
20. Effects of the lpr/lpr mutation on T and B cell populations in the lamina propria of the small intestine, a mucosal effector site.
Aicher WK; Fujihashi K; Yamamoto M; Kiyono H; Pitts AM; McGhee JR
Int Immunol; 1992 Sep; 4(9):959-68. PubMed ID: 1390438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
